1.A.5.3.3 Mucolipin-2 (TRPML2) non-selective plasma membrane cation channel (Ca2+ permeable). Shows inward rectification like TRPML1 and TRPML3 (Lev et al., 2010). Induces cell degeneration. Causes embryonic lethality, pigmentation defects and deafness, and regulates the acidification of early endosomes (Noben-Trauth, 2011). Found in the plasma membrane and early- and late-endosomes as well as lysosomes. Activated by a transient reduction of extracellular sodium followed by sodium
replenishment, by small chemicals related to sulfonamides, and by PI(3,5)P2, a rare phosphoinositide
that naturally accumulates in the membranes of endosomes and lysosomes, and thus could act as a
physiologically relevant agonist (García-Añoveros and Wiwatpanit 2014). TRPML2 can form heteromultimers with TRPML1 and
TRPML3; in B-lymphocytes, TRPML2 and TRPML1 may play redundant roles. TRPML2
may play a role in immune cell
development and inflammatory responses (Cuajungco et al. 2015). The TRPML family hallmark is a large extracytosolic/lumenal domain (ELD) between TMSs S1 and S2. Viet et al. 2019 presented crystal structures of the tetrameric human TRPML2 ELD. The structures reveal structural responses to the conditions the TRPML2 ELD encounters as the channel traffics through the endolysosomal system.
|
Accession Number: | Q8IZK6 |
Protein Name: | Mucolipin-2 |
Length: | 566 |
Molecular Weight: | 65942.00 |
Species: | Homo sapiens (Human) [9606] |
Number of TMSs: | 7 |
Location1 / Topology2 / Orientation3: |
Membrane1 / Multi-pass membrane protein2 |
Substrate |
calcium(2+) |
---|
Entrez Gene ID: |
255231
|
Pfam: |
PF08016
|
KEGG: |
hsa:255231
|
|
[1] “Mutations in Mcoln3 associated with deafness and pigmentation defects in varitint-waddler (Va) mice.” Di Palma F. et.al. 12403827
[2] “The DNA sequence and biological annotation of human chromosome 1.” Gregory S.G. et.al. 16710414
[3] “The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).” The MGC Project Team et.al. 15489334
[4] “Complete sequencing and characterization of 21,243 full-length human cDNAs.” Ota T. et.al. 14702039
|
|
1: MARQPYRFPQ ARIPERGSGV FRLTVRNAMA HRDSEMKEEC LREDLKFYFM SPCEKYRARR
61: QIPWKLGLQI LKIVMVTTQL VRFGLSNQLV VAFKEDNTVA FKHLFLKGYS GTDEDDYSCS
121: VYTQEDAYES IFFAINQYHQ LKDITLGTLG YGENEDNRIG LKVCKQHYKK GTMFPSNETL
181: NIDNDVELDC VQLDLQDLSK KPPDWKNSSF FRLEFYRLLQ VEISFHLKGI DLQTIHSREL
241: PDCYVFQNTI IFDNKAHSGK IKIYFDSDAK IEECKDLNIF GSTQKNAQYV LVFDAFVIVI
301: CLASLILCTR SIVLALRLRK RFLNFFLEKY KRPVCDTDQW EFINGWYVLV IISDLMTIIG
361: SILKMEIKAK NLTNYDLCSI FLGTSTLLVW VGVIRYLGYF QAYNVLILTM QASLPKVLRF
421: CACAGMIYLG YTFCGWIVLG PYHDKFENLN TVAECLFSLV NGDDMFATFA QIQQKSILVW
481: LFSRLYLYSF ISLFIYMILS LFIALITDSY DTIKKFQQNG FPETDLQEFL KECSSKEEYQ
541: KESSAFLSCI CCRRRKRSDD HLIPIS